HT
BPMC

HAP Trading’s Blueprint Medicines BPMC Stock Holding History

HAP Trading’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,000
Closed -$1K – 2247
2021
Q4 		$1K Hold
10,000
– – ﹤0.01% 2432
2021
Q3 		$24K Buy
+10,000
New +$931K ﹤0.01% 1749
2021
Q1 		– Sell
-207,100
Closed -$515K – 1951
2020
Q4 		$515K Buy
+207,100
New +$21.8M 0.01% 613
2020
Q1 		– Sell
-25,100
Closed -$15K – 1223
2019
Q4 		$15K Buy
+25,100
New +$1.88M ﹤0.01% 941

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

HAP Trading's BPMC Position: Q1 2021 in Review

HAP Trading sold out of Blueprint Medicines (BPMC) in Q1 2021, closing a stake of 13,349 shares — an estimated $1.5M sold.

HAP Trading first reported a position in BPMC in Q4 2020 and held it in 1 quarter. The position peaked at $1.5M in Q4 2020. 263 funds tracked by Wall St. Rank hold BPMC as of Q1 2021.

  • HAP Trading reported no remaining Blueprint Medicines position as of Q1 2021 after selling out during the quarter.
  • HAP Trading sold 13,349 Blueprint Medicines shares in Q1 2021, an estimated $1.5M.
  • HAP Trading first reported a position in Blueprint Medicines in Q4 2020 and held it in 1 quarter.
  • HAP Trading's Blueprint Medicines position peaked at $1.5M in Q4 2020.
  • 263 funds tracked by Wall St. Rank held Blueprint Medicines as of Q1 2021.

Based on HAP Trading's 13F filing for Q1 2021, filed 14 May 2021.